Ledger.Open graph →

SEC Form D · filed August 1, 2018

LSK BioPartners, Inc

Offering

$20.0M

Sold

$20.0M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

SALT LAKE CITY, UT

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Sung Chul Kim · Salt Lake City, UTExec · Director Alex Kim · Salt Lake City, UTDirector Soo Whan Choi · Salt Lake City, UTExec · Director Ha Young Kim · Salt Lake City, UTDirector Weili Cheng · Salt Lake City, UTDirector Sung Chul Kim · Salt Lake City, UTExec · Director Alex Kim · Salt Lake City, UTDirector Soo Whan Choi · Salt Lake City, UTExec · Director Ha Young Kim · Salt Lake City, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗